HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Aptinyx (NASDAQ:APTX) from Buy to Neutral.
Expert Ratings for Quest Diagnostics
Over the past 3 months, 5 analysts have published their opinion on Quest Diagnostics (NYSE:DGX) stock. These analysts…